|
|
Article: New strategy for developing 'next-generation' malaria vaccines.
- Article from:
- Asian News International
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 Al Bawaba (Middle East) Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: ANI
Washington, Nov 3 (ANI): Experts have suggested a novel strategy for developing 'next-generation' malaria vaccines that will help targeting the long-term goal of eliminating and eradicating the deadly mosquito-borne disease.
While trials are underway testing the efficacy if GlaxoSmithKline Biologicals' (GSK Bio) RTS, S malaria vaccine, experts linked to PATH Malaria Vaccine Initiative (MVI) have suggested new approaches.
While most malaria vaccine candidates use one or more components of the malaria parasite to elicit an immune response, another approach uses a weakened form of the whole parasite.
MVI is working with ...